PharmiWeb4d
HIV Drugs Industry to Expand from USD 28.6 Billion in 2023 to USD 47.5 Bn by 2034 | States Transparency Market Research, Inc.
The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...
moneycontrol.com4d
VWAP and Current Price Comparison
VWAP, or volume-weighted average price, is a technical analysis tool used primarily on intraday charts. It provides a benchmark for the average price a security has traded at during the day ...
money.rediff2d
Cipla Ltd.
Dr Reddy's, Zydus Lifesciences,... Feb 19, 2025 19:23 Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue ...
Business Standard4d
Cipla Share Price
Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...
Mint2d
Cipla Profit & Loss Annual
Revenue 25,774.09 22,753.12 21,763.34 19,159.59 ...
Mint2d
Cipla Key Metrics
Return on investment - most recent fiscal year 16.16 ...
Indiatimes4d
Cipla Listing Information
The Listing Page of Cipla Ltd. presents the Incorporation Date, Public Issue Date, Book Closure dates, Face Value, Key Listing information, Indices it is a part of, and the Exchanges where the company ...
Indiatimes6d
Cipla Quarterly results
The Quarterly Results page of Cipla Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.